Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLPE.L Regulatory News (SLPE)

  • There is currently no data for SLPE

Quarterly Trading Statement

29 Sep 2016 07:00

RNS Number : 1267L
Standard Life Euro Pri Eqty Tst PLC
29 September 2016
 

Standard Life European Private Equity Trust PLC

 

1. Investment update for the quarter ended 30 June 2016

 

· NAV rose by 6.2% to 329.3p for the quarter ended 30 June 2016

· Realised gains and income during the quarter ended 30 June 2016 were £13.6 million (2.7% of NAV). The unrealised losses on the portfolio on a constant exchange rate basis were £3.6 million (0.7% of NAV); in addition, there were unrealised foreign exchange gains of £18.8 million (3.7% of NAV)

· 100.0% by value of the portfolio was valued by the respective underlying managers at 30 June 2016

· NAV total return was 18.2% for the nine months from 1 October 2015 to 30 June 2016. This was after including unrealised foreign exchange gains of £42.8 million (8.4% of NAV)

· Outstanding commitments were £314.3 million at 30 June 2016

· Liquid resources were £109.5 million at 30 June 2016

 

For the quarter ended 30 June 2016 the Company's net asset value per ordinary share ("NAV") rose by 6.2% to 329.3p, from 310.2p at 31 March 2016. At 30 June 2016 the Company's net assets were £509.7 million (31 March 2016 - £480.2 million). NAV total return was 18.2% for the nine months from 1 October 2015 to 30 June 2016.

 

The volume of new buy-out transactions rose modestly in the European private equity market in the second quarter of 2016, while the enterprise value of buy-outs announced increased materially to €27.3 billion, from €15.2 billion in the first quarter of 2016. The material uplift reflected growth in mid-market and particularly large/mega buy-out transactions. The second quarter also witnessed strong mergers and acquisitions activity in Europe and a continuing flow of exits from private equity controlled investments.

 

The closing value of the Company's portfolio of 49 private equity fund interests was £403.7 million at 30 June 2016 (31 March 2016 - £390.6 million). The total unrealised gains on the portfolio for the quarter ended 30 June 2016 were £15.2 million, comprising £3.6 million of unrealised losses on a constant exchange rate basis and £18.8 million of unrealised foreign exchange gains. The MSCI Europe Index (in euros) and the FTSE All Share Index (in sterling) fell by 1.8% and rose 3.5% respectively during the quarter. The unrealised foreign exchange gains were driven by the euro and the US dollar appreciating by 4.6% and 7.0% respectively relative to sterling over the quarter.

 

During the quarter ended 30 June 2016 the Company funded £12.3 million of draw downs (six months ended 31 March 2016 - £34.4 million) and received £28.0 million of distributions (six months ended 31 March 2016 - £80.4 million). The distributions received during the quarter generated £13.6 million of realised gains and income, which was equivalent to a return of 2.2 times the acquisition cost of the realised investments. Total draw downs and distributions for the nine months ended 30 June 2016 were £46.7 million and £108.4 million, respectively.

 

The Company made two new fund commitments in the quarter, with a commitment of €28.1 million to Sixth Cinven Fund and €23.0 million to Astorg VI. The Company had total outstanding commitments to its 49 private equity fund interests of £314.3 million at 30 June 2016 (31 March 2016 - £271.5 million). The Manager continues to believe that around £55 million of the Company's existing outstanding commitments are unlikely to be drawn.

 

At 30 June 2016 the Company had liquid resources of £109.5 million, comprising a cash balance of £69.0 million and £40.5 million invested at value (£39.4 million at cost) in UK and European equity index tracker funds (31 March 2016 - liquid resources of £94.0 million). The Company continues to have an undrawn £80 million syndicated revolving credit facility provided by Citibank and Societe Generale that expires in December 2020.

 

 

2. Activity since 30 June 2016

 

On 15 July 2016 the Company paid an interim dividend for the year ended 30 September 2016 of 1.80p per ordinary share.

 

During the period from 1 July to 27 September 2016 the Company funded £17.1 million of draw downs and received £17.6 million of distributions.

 

On 8 July the index tracker funds, having generated income of £1.7 million, were sold generating an overall realised gain of £2.3 million. At 27 September 2016 the Company had cash and money market balances of £106.6 million. The Company also had total outstanding commitments of £307.7 million.

 

It is anticipated that the Company will release its preliminary announcement for the financial year ending 30 September 2016 on or around 2 December 2016.

 

 

For further information please contact:-

 

Roger Pim or Peter McKellar at SL Capital Partners LLP (0131 245 0055)

 

Note:-

Standard Life European Private Equity Trust PLC is an investment company managed by SL Capital Partners LLP, the ordinary shares of which are admitted to listing by the UK Listing Authority and to trading on the Stock Exchange and which seeks to conduct its affairs so as to qualify as an investment trust under sections 1158-1165 of the Corporation Tax Act 2010. The Board of Standard Life European Private Equity Trust PLC is independent of Standard Life plc.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEVLFLQKFFBBZ
Date   Source Headline
4th Oct 20161:15 pmRNSQuarterly Disclosure
29th Sep 20167:00 amRNSEstimated Net Asset Value as at 31 August 2016
29th Sep 20167:00 amRNSQuarterly Trading Statement
26th Sep 201611:32 amRNSDirector Declaration
14th Sep 20169:45 amRNSUpdate research from QuotedData
1st Sep 20167:00 amRNSTotal Voting Rights
30th Aug 201611:57 amRNSHolding(s) in Company
26th Aug 20162:37 pmRNSTransaction in Own Shares
22nd Aug 20164:19 pmRNSTransaction in Own Shares
17th Aug 201611:42 amRNSTransaction in Own Shares
12th Aug 20167:00 amRNSEstimated Net Asset Value as at 31 July 2016
5th Aug 201610:46 amRNSTransaction in Own Shares
2nd Aug 20168:29 amRNSDirector Declaration
14th Jul 20167:00 amRNSEstimated Net Asset Value at 30 June 2016
4th Jul 20164:43 pmRNSQuarterly Disclosure
14th Jun 20167:00 amRNSEstimated NAV at 31 May 2016
27th May 20164:24 pmRNSCompany Secretary Change
27th May 20167:02 amRNSEstimated NAV at 30 April 2016
27th May 20167:00 amRNSHalf-year Report
10th May 20163:22 pmRNSInitiation research from QuotedData
14th Apr 20167:00 amRNSEstimated NAV at 31 March 2016
5th Apr 201610:00 amRNSHolding(s) in Company
1st Apr 201610:08 amRNSHolding(s) in Company
1st Apr 20169:24 amRNSQuarterly Disclosure
1st Apr 20169:16 amRNSTotal Voting Rights
31st Mar 20162:45 pmRNSTransaction in Own Shares
24th Mar 20162:05 pmRNSEstimated NAV at 29 February 2016
24th Mar 20162:00 pmRNSQuarterly Trading Statement
26th Feb 201610:48 amRNSDirector/PDMR Shareholding
24th Feb 20164:46 pmRNSEdison update on Standard Life Euro. Pvt. Equity
12th Feb 20167:00 amRNSEstimated NAV at 31 January 2016
20th Jan 20163:12 pmRNSResult of AGM
20th Jan 20163:09 pmRNSEstimated NAV at 31 December 2015
6th Jan 201611:49 amRNSQuarterly Disclosure
17th Dec 20155:00 pmRNSAnnual Financial Report
16th Dec 20153:04 pmRNSDirector/PDMR Shareholding
14th Dec 20157:00 amRNSEstimated NAV at 30 November 2015
7th Dec 20157:01 amRNSEstimated NAV at 31 October 2015
7th Dec 20157:00 amRNSPreliminary Results
14th Oct 20157:00 amRNSEstimated NAV at 30 September 2015
1st Oct 20157:30 amRNSQuarterly Disclosure
1st Oct 20157:30 amRNSTotal Voting Rights
25th Sep 20154:36 pmRNSTransaction in Own Shares
18th Sep 201512:02 pmRNSDebt Facility
16th Sep 20157:05 amRNSEstimated NAV at 31 August 2015
16th Sep 20157:00 amRNSQuarterly Trading Statement
14th Aug 20157:00 amRNSEstimated NAV at 31 July 2015
3rd Aug 201510:00 amRNSTotal Voting Rights
31st Jul 201512:42 pmRNSDirector/PDMR Shareholding
30th Jul 20152:49 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.